What is a stock summary page? Click here for an overview.
Current and historical daily PE Ratio for Merck & Co Inc (
) from 1990 to Apr 26 2025. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Merck & stock (MRK) PE ratio as of Apr 26 2025 is 12.04.
More Details
Merck & Co Inc (MRK) PE Ratio (TTM) Chart
Merck & Co Inc (MRK) PE Ratio (TTM) Historical Data
View and export this data going back to 1990. Start your Free Trial
Total 1214
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Merck & PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2025-04-26 | 12.0 | 2025-02-21 | 13.3 |
| 2025-04-25 | 12.0 | 2025-02-20 | 13.0 |
| 2025-04-24 | 11.6 | 2025-02-19 | 12.7 |
| 2025-04-23 | 11.5 | 2025-02-18 | 12.4 |
| 2025-04-22 | 11.5 | 2025-02-14 | 12.3 |
| 2025-04-21 | 11.3 | 2025-02-13 | 12.5 |
| 2025-04-17 | 11.3 | 2025-02-12 | 12.7 |
| 2025-04-16 | 11.1 | 2025-02-11 | 12.9 |
| 2025-04-15 | 11.4 | 2025-02-10 | 12.8 |
| 2025-04-14 | 11.5 | 2025-02-07 | 13.0 |
| 2025-04-11 | 11.5 | 2025-02-06 | 13.1 |
| 2025-04-10 | 11.3 | 2025-02-05 | 13.3 |
| 2025-04-09 | 11.9 | 2025-02-04 | 13.5 |
| 2025-04-08 | 11.5 | 2025-02-03 | 14.8 |
| 2025-04-07 | 11.8 | 2025-01-31 | 14.7 |
| 2025-04-04 | 11.9 | 2025-01-30 | 14.7 |
| 2025-04-03 | 12.6 | 2025-01-29 | 14.6 |
| 2025-04-02 | 12.6 | 2025-01-28 | 14.5 |
| 2025-04-01 | 12.7 | 2025-01-27 | 14.6 |
| 2025-03-31 | 13.1 | 2025-01-24 | 14.2 |
| 2025-03-28 | 13.0 | 2025-01-23 | 14.4 |
| 2025-03-27 | 13.0 | 2025-01-22 | 14.2 |
| 2025-03-26 | 13.1 | 2025-01-21 | 14.3 |
| 2025-03-25 | 13.1 | 2025-01-17 | 14.6 |
| 2025-03-24 | 13.7 | 2025-01-16 | 15.0 |
| 2025-03-21 | 13.8 | 2025-01-15 | 14.9 |
| 2025-03-20 | 14.1 | 2025-01-14 | 14.8 |
| 2025-03-19 | 14.0 | 2025-01-13 | 15.0 |
| 2025-03-18 | 14.1 | 2025-01-10 | 14.8 |
| 2025-03-17 | 14.1 | 2025-01-08 | 14.8 |
| 2025-03-14 | 14.1 | 2025-01-07 | 15.0 |
| 2025-03-13 | 14.1 | 2025-01-06 | 14.8 |
| 2025-03-12 | 13.9 | 2025-01-03 | 14.7 |
| 2025-03-11 | 14.1 | 2025-01-02 | 14.7 |
| 2025-03-10 | 14.2 | 2024-12-31 | 14.8 |
| 2025-03-07 | 14.1 | 2024-12-30 | 14.6 |
| 2025-03-06 | 14.0 | 2024-12-27 | 20.9 |
| 2025-03-05 | 13.8 | 2024-12-26 | 20.9 |
| 2025-03-04 | 13.8 | 2024-12-24 | 20.9 |
| 2025-03-03 | 13.8 | 2024-12-23 | 20.8 |
| 2025-02-28 | 13.7 | 2024-12-20 | 20.6 |
| 2025-02-27 | 13.5 | 2024-12-19 | 20.9 |
| 2025-02-26 | 13.3 | 2024-12-18 | 20.6 |
| 2025-02-25 | 13.6 | 2024-12-17 | 21.0 |
| 2025-02-24 | 13.6 | 2024-12-16 | 21.0 |
Merck & Co Inc (MRK) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Merck & Co Inc
NAICS : 325412
SIC : 2834
ISIN : US58933Y1055
Compare
Compare
Traded in other countries / regions
MRK.USA0QAH.UKMRCK34.BrazilMRK.Canada6MK.GermanyMRK.ArgentinaMRK.Mexico1MRKX.ItalyMRK.PeruMRK.Austria6MK.BulgariaMRK.ChileMRK.FranceMRK.Ukraine Index Membership
Dow 30S&P 500Russell 1000Russell 3000 IPO Date
1949-04-20Description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers